For 17 years he has sold radiation therapy systems-suddenly he finds himself in dire need of them.

Don Mills, 50, is a Varian Medical Systems salesman. A gentle and reserved man with a wife and two daughters, he is fit as only a 30-mile-per-week runner (sun, rain, or snow) can be. He's also a prostate cancer patient who, having considered his family, lifestyle, and the available remedies, chose intensity modulated radiation therapy. Don is one of a growing number of patients who have chosen IMRT for treating their breast, prostate, lung, or head and neck cancer.

"Before I was ever diagnosed I was awed by IMRT," Mills explains. "It's the most dramatic advance in the 20 years I've been involved with radiotherapy." Living in New York during his treatment at Memorial Sloan-Kettering Cancer Center, he runs at dawn through Central Park and gets therapy later in the morning. "I'm being treated from five angles," Mills says, "yet I'm in and out in 10 minutes. Before IMRT this would have been impossible.

"I'm staking my life on this technology. I have complete confidence in it, and in the therapists and professionals helping me."

DON MILLS, Varian Medical Systems salesman and prostate cancer patient

"I looked at the data, the recuperation times, and the outcomes for different procedures. IMRT had the highest success rate with the fewest complications- and it was the least disruptive. Given my age, lifestyle, and background, IMRT was the best choice for me."
DON MILLS, Varian Medical Systems salesman and prostate cancer patient

In 1999 in the United States alone, approximately 37,000 deaths resulted from prostate cancer, and an estimated 179,300 new cases were diagnosed- more than for any other type of cancer in either men or women. Thanks largely to prostate-specific antigen (PSA) blood test screenings and earlier detection in general, the survival rate for all stages of prostate cancer increased from 67% to 93% over the past 20 years.2

2 "Cancer Facts and Figures-1999," The American Cancer Society

logo
1999 Annual Report

Previous | Table of Contents | Next